Mangalam Drugs & Organics Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 899.551 million compared to INR 626.026 million a year ago. Net income was INR 64.342 million compared to INR 16.513 million a year ago. Basic earnings per share from continuing operations was INR 4.07 compared to INR 1.04 a year ago. For the nine months, total revenue was INR 2,919.604 million compared to INR 1,949.869 million a year ago. Net income was INR 258.167 million compared to INR 31.985 million a year ago. Basic earnings per share from continuing operations was INR 16.31 compared to INR 2.02 a year ago.